WallStSmart
PDSB

PDS Biotechnology Corp

NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY

$0.97
+1.32% today

Updated 2026-04-30

Market cap
$60.28M
P/E ratio
P/S ratio
EPS (TTM)
$-0.74
Dividend yield
52W range
$1 – $2
Volume
0.8M

PDS Biotechnology Corp (PDSB) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20122013201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$2183.00$53116.00$100117.00$182918.00$69118.00$98414.00$176292.00$246388.00$49078.00$57326.00$59791.00$60518.00
Gross profit$-2183.00$-53116.00$-100000.00$-183000.00$-69118.00$-98414.00$-176292.00$-246388.00$-49078.00$-57326.00$-59791.00$-60518.00
Gross margin
R&D$3.71M$4.48M$8.47M$17.84M$24.82M$34.31M$830744.00$6.10M$7.92M$11.25M$29.43M$27.76M$22.57M$19.03M
SG&A$2.00M$4.72M$8.66M$14.69M$17.66M$14.29M$10.98M$6.79M$10.18M$12.24M$15.02M$13.49M$12.52M
Operating income$-4.69M$-6.49M$-13.19M$-26.50M$-39.51M$-51.97M$-43.10M$-15.51M$-14.90M$-21.44M$-41.67M$-43.05M$-36.32M$-31.54M
Operating margin
EBITDA$-4.69M$-7.33M$-12.58M$-28.32M$-39.36M$-51.08M$-3.58M$-7.25M$-14.89M$-21.43M$-40.74M$-40.09M$-33.75M$-30.30M
EBITDA margin
EBIT$-4.70M$-7.34M$-12.61M$-28.37M$-39.46M$-51.27M$-3.65M$-7.35M$-14.90M$-21.43M$-40.74M$-40.14M$-33.81M$-30.33M
Interest expense$2653.00$3354.00$183179.00$816494.00$1.20M$2.18M$1.43M$33559.00$32953.00$4346.00$1.32M$4.21M$4.67M$5.34M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.70M$-6.88M$-12.20M$-28.08M$-38.82M$-50.86M$-40.87M$-7.00M$-14.85M$-16.92M$-40.85M$-42.94M$-37.61M$-34.50M
Net income growth (YoY)-46.5%-77.3%-130.1%-38.3%-31.0%+19.6%+82.9%-112.1%-13.9%-141.5%-5.1%+12.4%+8.3%
Profit margin